Table 2 Number of events and incidence rates for all-cause and cardiovascular mortality in US adults by NT-ProBNP values
From: NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
NT-ProBNP (pg/ml) | ||||
|---|---|---|---|---|
| Â | All-cause mortality | Cardiovascular mortality | ||
Events (n/N) | Incidence rate per 1000 person-years (95% CI) | Events (n/N) | Incidence rate per 1000 person-years (95% CI) | |
Entire cohort | ||||
  < 100 | 655/3446 | 14.8 (13.7–15.9) | 123/3446 | 2.8 (2.3–3.3) |
 100–299 | 499/1462 | 29.0 (26.6–31.7) | 116/1462 | 6.7 (5.6–8.1) |
  ≥ 300 | 355/585 | 64.2 (57.8–71.2) | 91/585 | 16.5 (13.4–20.2) |
HbA1c < 5.7% | ||||
  < 100 | 323/2144 | 11.5 (10.3–12.9) | 59/2144 | 2.1 (1.6–2.7) |
 100–299 | 284/925 | 25.3 (22.6–28.5) | 53/925 | 4.7 (3.6–6.2) |
  ≥ 300 | 169/305 | 55.6 (47.8–64.6) | 33/305 | 10.8 (7.7–15.3) |
HbA1c 5.7–6.4% | ||||
  < 100 | 151/727 | 16.5 (14.0–19.3) | 24/727 | 2.6 (1.8–3.9) |
 100–299 | 92/280 | 28.4 (23.1–34.7) | 27/280 | 8.3 (5.7–12.2) |
  ≥ 300 | 75/116 | 69.9 (55.7–87.6) | 22/116 | 20.5 (13.5–31.1) |
Diabetes | ||||
  < 100 | 181/575 | 25.7 (22.2–29.8) | 40/575 | 5.7 (4.2–7.8) |
 100–299 | 123/257 | 44.7 (37.5–53.3) | 36/257 | 13.1 (9.4–18.1) |
  ≥ 300 | 111/164 | 78.4 (65.1–94.4) | 36/164 | 25.4 (18.3–35.2) |